Regulation of Erythroid Cell Progenitors by the Nuclear Receptor Transcription Factor VDR
Regulation of Erythroid Cell Progenitors by the Nuclear Receptor Transcription Factor VDR
批准号:
9976495
负责人:
Margaret H Baron
金额:
$61.56万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-06 至 2023-04-30
关键词:
ARNTL geneATAC-seqAblationAdultAgonistAnemiaAnimalsBone MarrowCalcitriolCell Culture TechniquesCell LineCell NucleusCellsCholecalciferolChromatinCircadian RhythmsClinicalComplexControl AnimalDNA BindingDevelopmentDexamethasoneDiseaseEffectivenessEmbryoEngineeringErythrocyte TransfusionErythrocytesErythroidErythroid Progenitor CellsErythropoiesisFetal LiverGATA1 geneGene ExpressionGene Expression ProfilingGenesGeneticGenetic TranscriptionGlucocorticoid ReceptorGlucocorticoidsGrowthHematological DiseaseHematopoieticKnockout MiceKnowledgeLeadLeukemic CellLigandsMissionModelingMolecular ConformationMolecular TargetMutationNuclear Hormone ReceptorsNuclear ReceptorsOutputPathway interactionsPeriodicityProcessProductionProteinsPublic HealthPublishingRNAReceptor ActivationReceptor SignalingRecoveryRegulationReticulocytosisRoleSignal PathwayStressTestingTimeUnited States National Institutes of HealthUp-RegulationVitamin D3 Receptorbonecircadian pacemakerconditional mutanterythroid differentiationfetalknock-downmouse modelmutantnovelnovel therapeuticsprogenitorreceptor expressionrecruitresponsetooltranscription factorvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT: The pathways that regulate the formation and differentiation of erythroid progenitors to red blood
cells are incompletely understood. We found that the vitamin D receptor (Vdr) nuclear hormone transcription
factor gene is expressed in fetal and adult stages but not at the embryonic stage of development and is
downregulated during maturation. VDR activation by its ligand vitamin D3 results in conformational changes
that stabilize the protein and induce its translocation into the nucleus, where it recruits coregulatory complexes.
The VDR signaling pathway has been studied mostly in bone but has been largely unexplored in
erythropoiesis: published studies were performed almost entirely in leukemic cell lines (not normal primary
cells). Activation of Vdr signaling by the vitamin D3 agonist calcitriol increased the outgrowth of EryD colonies
from fetal liver and adult bone marrow, maintained progenitor potential, and delayed erythroid maturation. The
stimulation in growth of erythroid progenitors resulted in a large increase in the numbers of mature red blood
cells. The early (CD71lo/neg) but not the late (CD71hi) EryD progenitor subset of Linneg cKit+ cells was responsive
to calcitriol, independently of its calcemic effects. Activation of VDR could partially substitute for and
synergize with the stress glucocorticoid dexamethasone in enhancing progenitor proliferation compared to
either ligand alone, suggesting a role in stress erythropoiesis. This possibility is supported by our finding that
an erythroid specific deletion in Vdr that interferes with DNA binding results in a reticulocytosis that occurs
earlier and is more pronounced than in control animals in response to stress. RNA inhibition of Vdr expression
abrogated the stimulation of early erythroid progenitor growth by calcitriol. These findings suggest that Vdr has
a cell-intrinsic function in early erythroid progenitors. Activation of Vdr by calcitriol blocked the upregulation of
erythroid transcription factor genes Gata1, Fog1 and Klf1. Intriguingly, circadian rhythm genes are
upregulated by activation of Vdr and the glucocorticoid receptor Gr and oscillations in expression of the clock
gene Per1 are promoted in erythroid progenitors. The clock gene Bmal1 is required for the proliferative
response to dexamethasone. Therefore, the overarching hypothesis of this proposal is that Vdr and Gr
regulate erythroid progenitors in part by modulating clock gene expression and have partially redundant
functions. This application will use animal and cell culture models to explore the modulation of circadian clock
gene expression by Gr and Vdr in erythroid progenitors and functional relationships between these two nuclear
hormone receptor TFs. These studies may lead to the identification of novel molecular targets in erythroid
progenitors that can be exploited to develop new therapies for anemias and other red cell disorders. The ability
to modulate ex vivo expansion or differentiation of RBC progentors in new ways would have clear clinical utility.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Erythroid Cell Progenitors by the Nuclear Receptor Transcription Factor VDR
-
批准号:10392918
-
项目类别:
-
资助金额:$58.73万
-
财政年份:2015
-
负责人:Margaret H Baron
-
依托单位:
Regulation of Erythropoiesis by the VDR Nuclear Receptor Transcription Factor
-
批准号:9260873
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2015
-
负责人:Margaret H Baron
-
依托单位:
Regulation of Erythropoiesis by the VDR Nuclear Receptor Transcription Factor
-
批准号:9052176
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2015
-
负责人:Margaret H Baron
-
依托单位:
Erythroid Development in the Mammalian Embryo
-
批准号:8010035
-
项目类别:
-
资助金额:$9.95万
-
财政年份:2010
-
负责人:Margaret H Baron
-
依托单位:
Research Training Program in Molecular and Cellular Hematology
-
批准号:7939604
-
项目类别:
-
资助金额:$13.37万
-
财政年份:2009
-
负责人:Margaret H Baron
-
依托单位:
Research Training Program in Molecular and Cellular Hematology
-
批准号:7762477
-
项目类别:
-
资助金额:$6.51万
-
财政年份:2009
-
负责人:Margaret H Baron
-
依托单位:
Research Training Program in Molecular and Cellular Hematology
-
批准号:8128585
-
项目类别:
-
资助金额:$21.23万
-
财政年份:2009
-
负责人:Margaret H Baron
-
依托单位:
Erythroid Development in the Mammalian Embryo
-
批准号:7853710
-
项目类别:
-
资助金额:$1.28万
-
财政年份:2009
-
负责人:Margaret H Baron
-
依托单位:
Research Training Program in Molecular and Cellular Hematology
-
批准号:8496860
-
项目类别:
-
资助金额:$25.01万
-
财政年份:2009
-
负责人:Margaret H Baron
-
依托单位:
Research Training Program in Molecular and Cellular Hematology
-
批准号:8320212
-
项目类别:
-
资助金额:$24.64万
-
财政年份:2009
-
负责人:Margaret H Baron
-
依托单位:
Methods for Modulating Hemato-Vascular Development
-
批准号:7098055
-
项目类别:
-
资助金额:$34.19万
-
财政年份:2003
-
负责人:Margaret H Baron
-
依托单位:
Methods for Modulating Hemato-Vascular Development
-
批准号:6929903
-
项目类别:
-
资助金额:$35.01万
-
财政年份:2003
-
负责人:Margaret H Baron
-
依托单位:
Methods for Modulating Hemato-Vascular Development
-
批准号:7276646
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2003
-
负责人:Margaret H Baron
-
依托单位:
Methods for Modulating Hemato-Vascular Development
-
批准号:6802291
-
项目类别:
-
资助金额:$35.01万
-
财政年份:2003
-
负责人:Margaret H Baron
-
依托单位:
Methods for Modulating Hemato-Vascular Development
-
批准号:6723915
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2003
-
负责人:Margaret H Baron
-
依托单位:
Induction and Specification of Hematopoietic Mesoderm
-
批准号:7683826
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2000
-
负责人:Margaret H Baron
-
依托单位:
Induction and Specification of Hematopoietic Mesoderm
-
批准号:7492895
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2000
-
负责人:Margaret H Baron
-
依托单位:
ACTIVATION OF HEMATOPOIESIS IN THE MOUSE EMBRYO
-
批准号:6127103
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2000
-
负责人:Margaret H Baron
-
依托单位:
Induction and Specification of Hematopoietic Mesoderm
-
批准号:8706940
-
项目类别:
-
资助金额:$41.53万
-
财政年份:2000
-
负责人:Margaret H Baron
-
依托单位:
Induction and Specification of Hematopoietic Mesoderm
-
批准号:7918177
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2000
-
负责人:Margaret H Baron
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵
袭的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:柳静
-
依托单位:
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
-
批准号:62302218
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:张双全
-
依托单位:
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:黄铭坤
-
依托单位:
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
-
批准号:32100438
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:涂晓雨
-
依托单位:
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
-
批准号:82001520
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:汤小晗
-
依托单位:
靶向治疗动态调控肺癌细胞DNA可接近性的ATAC-seq分析
-
批准号:81802809
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:蔡梅春
-
依托单位:
运用ATAC-seq技术分析染色质可接近性对犏牛初级精母细胞基因表达的调控作用
-
批准号:31802046
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2018
-
负责人:张龚炜
-
依托单位:
基于ATAC-seq和RNA-seq研究CWIN调控采后番茄果实耐冷性作用机制
-
批准号:31801915
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2018
-
负责人:茹磊
-
依托单位:
基于ATAC-seq高精度预测染色质相互作用的新方法和基于增强现实的3D基因组数据可视化
-
批准号:31871331
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:张治华
-
依托单位: